Cargando…
Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751459/ https://www.ncbi.nlm.nih.gov/pubmed/26867695 http://dx.doi.org/10.1038/srep20750 |
_version_ | 1782415585644118016 |
---|---|
author | Takahashi, Hiroto Xia, Peng Cui, Jiankun Talantova, Maria Bodhinathan, Karthik Li, Wenjun Saleem, Sofiyan Holland, Emily A. Tong, Gary Piña-Crespo, Juan Zhang, Dongxian Nakanishi, Nobuki Larrick, James W. McKercher, Scott R. Nakamura, Tomohiro Wang, Yuqiang Lipton, Stuart A. |
author_facet | Takahashi, Hiroto Xia, Peng Cui, Jiankun Talantova, Maria Bodhinathan, Karthik Li, Wenjun Saleem, Sofiyan Holland, Emily A. Tong, Gary Piña-Crespo, Juan Zhang, Dongxian Nakanishi, Nobuki Larrick, James W. McKercher, Scott R. Nakamura, Tomohiro Wang, Yuqiang Lipton, Stuart A. |
author_sort | Takahashi, Hiroto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4751459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-47514592016-02-22 Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease Takahashi, Hiroto Xia, Peng Cui, Jiankun Talantova, Maria Bodhinathan, Karthik Li, Wenjun Saleem, Sofiyan Holland, Emily A. Tong, Gary Piña-Crespo, Juan Zhang, Dongxian Nakanishi, Nobuki Larrick, James W. McKercher, Scott R. Nakamura, Tomohiro Wang, Yuqiang Lipton, Stuart A. Sci Rep Corrigenda Nature Publishing Group 2016-02-12 /pmc/articles/PMC4751459/ /pubmed/26867695 http://dx.doi.org/10.1038/srep20750 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Corrigenda Takahashi, Hiroto Xia, Peng Cui, Jiankun Talantova, Maria Bodhinathan, Karthik Li, Wenjun Saleem, Sofiyan Holland, Emily A. Tong, Gary Piña-Crespo, Juan Zhang, Dongxian Nakanishi, Nobuki Larrick, James W. McKercher, Scott R. Nakamura, Tomohiro Wang, Yuqiang Lipton, Stuart A. Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title | Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title_full | Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title_fullStr | Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title_full_unstemmed | Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title_short | Corrigendum: Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease |
title_sort | corrigendum: pharmacologically targeted nmda receptor antagonism by nitromemantine for cerebrovascular disease |
topic | Corrigenda |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751459/ https://www.ncbi.nlm.nih.gov/pubmed/26867695 http://dx.doi.org/10.1038/srep20750 |
work_keys_str_mv | AT takahashihiroto corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT xiapeng corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT cuijiankun corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT talantovamaria corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT bodhinathankarthik corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT liwenjun corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT saleemsofiyan corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT hollandemilya corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT tonggary corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT pinacrespojuan corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT zhangdongxian corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT nakanishinobuki corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT larrickjamesw corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT mckercherscottr corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT nakamuratomohiro corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT wangyuqiang corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease AT liptonstuarta corrigendumpharmacologicallytargetednmdareceptorantagonismbynitromemantineforcerebrovasculardisease |